Drug Shortage Report for EXTAVIA
| Report ID | 100125 |
| Drug Identification Number | 02337819 |
| Brand name | EXTAVIA |
| Common or Proper name | EXTAVIA 30G/VIAL 0.3MG (X15) |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | INTERFERON BETA-1B |
| Strength(s) | 0.3MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | X15 |
| ATC code | L03AB |
| ATC description | IMMUNOSTIMULANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-12-12 |
| Actual start date | |
| Estimated end date | 2020-03-04 |
| Actual end date | 2020-03-06 |
| Shortage status | Resolved |
| Updated date | 2020-03-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2020-03-09 | French | Compare |
| v12 | 2020-03-09 | English | Compare |
| v11 | 2020-02-28 | French | Compare |
| v10 | 2020-02-28 | English | Compare |
| v9 | 2020-02-24 | French | Compare |
| v8 | 2020-02-24 | English | Compare |
| v7 | 2020-02-24 | French | Compare |
| v6 | 2020-02-24 | English | Compare |
| v5 | 2020-02-04 | French | Compare |
| v4 | 2020-02-04 | English | Compare |
| v3 | 2019-12-13 | English | Compare |
| v2 | 2019-12-03 | French | Compare |
| v1 | 2019-12-03 | English | Compare |
Showing 1 to 13 of 13